<Flipbook Here>Check out this quarter's highlights! From exciting company announcements to celebrating our GEM Winner, team updates, and high fives for shared successes—there's plenty to explore. Dive in and enjoy the latest from BPSI!...
All
All Blogs – Clinical Research
Risk Management in Clinical Trials: The Sub-Investigators Role in Protecting Sponsor Investments
Clinical trials are a cornerstone of pharmaceutical development, entailing significant investment in terms of time, money, and resources. These early stage clinical trials are fraught with various risks ranging from clinical failures to regulatory issues, all of which...
Understanding Flip-Flop Pharmacokinetics: Challenges and Strategies in Drug Development
Pharmacokinetics (PK) modeling has been a useful tool thorough from pre-clinic to clinical (from Phase 1 to 3) in drug development, clinical research, and therapeutic optimization for centuries. The PK model used quantitative parameters to describe the complex...
Embracing Global Diversity: Celebrating Cultural Heritage in the Workplace
BioPharma Services Inc. is a place where diversity truly thrives. It isn’t just a buzzword—it’s the heartbeat of our organization. With team members hailing from all corners of the globe, our workplace is a vibrant mosaic of cultures, languages, and traditions....
The Role of IND-enabling Studies
IND-enabling studies are crucial for advancing a New Chemical Entity (NCE) from preclinical evaluation to its first-in-human clinical trial. These studies comprehensively assess the NCE's safety, pharmacology, and manufacturing processes, leading to the submission of...
The Essentials and Importance of Phase 1 Clinical Trial Design
Clinical drug development progresses with the conduct of clinical trials, with different phases of clinical trials focusing on different aspects of the development process. Phase 1 clinical trials, including first-in-human studies, evaluate the safety and dose range...